Relay Therapeutics, Inc. (RLAY) Balance Sheet
As of 2026-06-30 (10-Q), Relay Therapeutics, Inc. (RLAY) reported total assets of $967.5M, total liabilities of $77.4M and shareholders' equity of $890.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $121.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RLAYRelay Therapeutics, Inc.Follow RLAY — free
—
Price chart with a free account
- Market cap
- 4.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.45 | 0.28 | 0.15 | 0.14 | 0.12 | 0.08 | 0.12 | |
| Receivables | 0.08 | 0.00 | 0.00 | — | — | — | — | |
| Current assets | 0.77 | 0.98 | 1.02 | 0.77 | 0.81 | 0.58 | 0.93 | |
| Total assets | 0.80 | 1.01 | 1.10 | 0.84 | 0.87 | 0.62 | 0.97 | |
| Current liabilities | 0.01 | 0.02 | 0.06 | 0.03 | 0.05 | 0.03 | 0.05 | |
| Total liabilities | 0.04 | 0.11 | 0.15 | 0.09 | 0.09 | 0.05 | 0.08 | |
| Shareholders' equity | 0.76 | 0.90 | 0.95 | 0.75 | 0.78 | 0.57 | 0.89 |
USD billions · SEC XBRL
Relay Therapeutics, Inc. — questions
- How much cash does Relay Therapeutics, Inc. have?
- $121.2M in cash and cash equivalents as of 2026-06-30.
- What are Relay Therapeutics, Inc.'s total assets?
- $967.5M as of 2026-06-30.
- What is Relay Therapeutics, Inc.'s shareholders' equity?
- $890.0M as of 2026-06-30.
Every figure on this page comes from Relay Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.